Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression
Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmstrom C, Panossian A
Published in Nordic Journal of Psychiatry, Vol. 61 (5), pp. 343-8
Methodology
Randomized double-blind placebo-controlled trial of standardized Rhodiola rosea extract in patients with mild to moderate depression.
Key Findings
Rhodiola improved overall depression, insomnia and emotional instability scores versus placebo.
Conclusions
Rhodiola may restore drive and pleasure response in mild depression.
Limitations
Small sample; single trial not replicated at scale.
Supplements Studied
Rhodiola improved overall depression, insomnia and emotional instability scores versus placebo
Outcomes Measured
Rhodiola improved overall depression, insomnia and emotional instability scores versus placebo
Rhodiola improved overall depression, insomnia and emotional instability scores versus placebo
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.